<DOC>
	<DOC>NCT02546128</DOC>
	<brief_summary>To assess whether the addition of Extra-corporeal Shockwave Therapy (ESWT) to a structured home-exercise programme has any additional benefit to patients with tendinopathies</brief_summary>
	<brief_title>LEICeSter Tendon Extracorporeal Shockwave Studies</brief_title>
	<detailed_description />
	<mesh_term>Tendinopathy</mesh_term>
	<criteria>1. Patients age &gt;18 2. Symptoms (typically pain / stiffness) of at least 12 weeks of one of the following sites / conditions: 1. Plantar fasciitis 2. Insertional Achilles tendinopathy 3. Midsubstance Achilles tendinopathy 4. Patella tendinopathy 5. Trochanteric pain syndrome (gluteus medius insertional tendinopathy / trochanteric bursitis) 6. Tennis elbow 3. Referred for ESWT (shockwave) within the Sports Medicine Department 4. Objective imaging of tendon / structure confirming diagnosis and excluding tear or other structural injury (US or MRI acceptable) 1. Patients with the normal exclusions for ESWT including preexisting skin injury over tendon site, recent steroid injection (within 6 weeks of ESWT starting), patients on anticoagulation, patients with haemophilia or other bleeding tendency, patients with current febrile illness 2. Previous ESWT treatment for the same condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>